In healthcare, medication is an essential component of treatment. At CVS Health®, we believe in promoting the use of high-quality and cost-effective medications, including biosimilar drugs. Biosimilars are a game-changer for patients who require treatment for chronic and severe conditions. These medications can be used to treat a wide range of conditions, from certain types of cancer to diabetes, and they represent a significant opportunity for managing drug costs within the healthcare system.
In a recent report authored by Dr. Sree Chaguturu, Executive Vice President and Chief Medical Officer at CVS Health, the benefits of biosimilar drugs in making treatments more affordable were highlighted. The report also discussed the role of Cordavis™, a CVS Health subsidiary that focuses on producing high-quality biosimilars, in improving patient access to these life-changing treatments and driving innovation in healthcare.
The impact of biosimilar drugs cannot be overstated. These medications have the potential to make healthcare more accessible by making treatments more affordable for patients who need them most. By using these medications instead of expensive branded drugs, patients can save money while still receiving effective treatment for their chronic or severe conditions. This is especially important for those who are struggling financially or have limited insurance coverage.
To learn more about the impact of biosimilar drugs and how they are making healthcare more accessible, you can read the full report (PDF) authored by Dr. Sree Chaguturu. In it, you will find detailed information on the benefits of these medications and how they are being used to improve patient outcomes and reduce costs within the healthcare system.